
Novel highly мощный and селективный TYK2 JH2 ингибитор, providing robust inhibition in a mouse IL-12-induced IFNγ pharmacodynamic model as well as efficacy in an IL-23 and IL-12-dependent mouse colitis model
Novel highly potent and selective TYK2 JH2 inhibitor, providing robust inhibition in a mouse IL-12-induced IFNγ pharmacodynamic model as well as efficacy in an IL-23 and IL-12-dependent mouse colitis model
Только для научно-исследовательского применения. Не предназначено для использования у пациентов или в качестве лекарственного средства.